What is the recommended titration protocol for weaning vasopressin in an adult patient with vasodilatory shock?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: March 16, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Vasopressin Weaning Protocol in Vasodilatory Shock

Vasopressin should be weaned after norepinephrine has been successfully reduced, as withdrawing vasopressin first is associated with greater hemodynamic instability. 1

Timing of Vasopressin Discontinuation

  • Begin weaning vasopressin only after norepinephrine requirements have decreased to low doses (approximately 0.2 µg/kg/min or less). 2
  • The sequence of vasopressor withdrawal should prioritize reducing norepinephrine first while maintaining vasopressin at its fixed dose, as demonstrated in major trials (VASST and VANISH). 1
  • Vasopressin should be withdrawn in small, gradual steps according to the mean arterial pressure response. 2

Practical Weaning Strategy

  • Maintain vasopressin at a fixed dose (typically 0.03-0.04 units/min) while titrating down norepinephrine to achieve target MAP of 65 mmHg. 3, 4
  • Once norepinephrine has been reduced to approximately 0.2 µg/kg/min, begin stepwise reduction of vasopressin while monitoring hemodynamic response. 2
  • The pressor effect of vasopressin fades within 20 minutes after stopping the infusion, allowing for relatively rapid assessment of hemodynamic stability. 5

Monitoring During Weaning

  • Continuous arterial blood pressure monitoring is essential during vasopressor weaning. 3, 4
  • Monitor for signs of adequate perfusion including lactate clearance, urine output, mental status, and mixed or central venous oxygen saturation. 1
  • Assess cardiac output and tissue perfusion using echocardiography and serial lactate measurements at regular intervals. 1

Important Caveats

  • Never use vasopressin as a single vasopressor agent - it must always be combined with catecholamines, particularly norepinephrine. 4, 6
  • Computerized-assisted weaning protocols may reduce unnecessary exposure to vasoactive drugs and should be considered when available. 1
  • The importance of vasoactive agent de-escalation is comparable to the indication for initiation, as clinicians may maintain higher blood pressures than necessary due to overestimating the risk of hemodynamic deterioration. 1
  • Vasopressin weaning should be performed as soon as hemodynamic stabilization is achieved to minimize potential adverse effects including decreased cardiac output, arrhythmias, and ischemic complications. 1, 5

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.